HUM · 8-K · 20261106PR000064
Guidance / Outlook
HUMANA INC · 2026-11-06 · Importance 82 · Surprise 100 · In source text
Humana raised FY 2026 adjusted EPS guidance to at least $9.50 from at least $9.00. GAAP EPS guidance increased to at least $15.09 from at least $6.52. The company said adjusted guidance anticipates a year-over-year decline due to the Star Ratings headwind for Bonus Year 2026, net of mitigation.
Key facts
- Humana revised FY 2026 GAAP EPS guidance to at least $15.09 from at least $6.52. source
- Humana’s FY 2026 GAAP EPS guidance is at least $15.09, compared with FY 2025 GAAP EPS of $9.84. source
- Humana’s FY 2026 projected adjusted EPS guidance is at least $9.50, compared with FY 2025 reported adjusted EPS of $17.14. source
- Humana’s FY 2026 GAAP EPS guidance may change due to ongoing value creation and other strategic initiatives; the company does not expect changes to its FY 2026 adjusted EPS guidance. source
- Humana’s FY 2026 adjusted EPS guidance excludes future value changes that have not yet been recognized and cannot currently be reasonably estimated. source
- Humana raised FY 2026 adjusted EPS guidance to at least $9.50 from at least $9.00. source
- Humana expects FY 2026 adjusted EPS to decline year over year due to the Star Ratings headwind for BY 2026, net of mitigation. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | committed | — | Humana revised FY 2026 GAAP EPS guidance to at least $15.09 from at least $6.52. |